Redesigned Laboratory Automation by UniteLabs
In the heart of Munich, Germany, a groundbreaking startup named UniteLabs is making waves in the world of biotechnology. Founded by Robert Zechlin, Lukas, and Julian in early 2024, following a shared apartment and a research project on "Digitalization in Industrial Biotechnology", UniteLabs is set to redefine laboratory automation.
The founders, who met in 2022, have been on a long-term mission to break down vendor barriers, reduce costs, and create a scalable infrastructure for AI-driven laboratory automation. Despite the challenges, particularly the international presence of the startup from the beginning, UniteLabs has some exciting things in the pipeline that will attract early attention.
UniteLabs offers an innovative integration infrastructure, the only open, cross-manufacturer solution for AI-driven laboratory automation. This platform provides several key features, including bidirectional interfaces, a scalable cloud platform, a powerful workflow engine, and a "lab-as-code" approach.
The bidirectional interfaces support the integration of a wide range of laboratory devices, ensuring seamless communication and data exchange across different hardware. The scalable cloud platform, with an open API, allows for the integration of various applications and enables the development of modular workflows, facilitating customization and scalability.
The powerful workflow engine enables the creation of sophisticated workflows, automating laboratory processes and making it easier to manage and optimize experiments. The "lab-as-code" approach, leveraging a dynamic Python SDK and application-specific libraries, facilitates rapid automation development and allows for the integration of AI-driven tools and processes, further enhancing laboratory efficiency.
UniteLabs' initial focus is on laying the foundation for creating a stable and scalable infrastructure for the core processes of partially regulated companies. The platform enables improved data integrity, process automation, and instrument monitoring, making it an essential tool for biotech companies and research institutions.
Robert Zechlin, a founder of UniteLabs, expresses that Munich is a great location for the startup, benefiting from the community and being a life sciences hotspot with the most active laboratory automation community in all of Europe. UniteLabs now has partners all over the world, including a recent research proposal with a Korean partner.
UniteLabs' long-term vision is to set the global standard for lab automation and make cutting-edge biotech research faster, smarter, and more connected than ever before. With a goal to connect 90 lab devices by the end of the year, UniteLabs is making lab automation accessible to nearly half of all biotech labs worldwide.
The value of UniteLabs' platform increases with the number of connectors developed and the number of devices they can integrate. UniteLabs is the only platform that combines complete device integration, including control, with a development environment. The startup's solution addresses the bottleneck of hardware integration in laboratory automation by standardizing and simplifying the integration process.
In summary, UniteLabs is a game-changer in the field of AI-driven laboratory automation, offering an open, cross-manufacturer solution that promises to revolutionise the way laboratories operate. With its innovative features and global vision, UniteLabs is poised to make a significant impact in the biotech industry.
- UniteLabs, with its innovative platform, aims to connect 90 lab devices by the end of the year, making lab automation accessible to nearly half of all biotech labs worldwide.
- The founders of UniteLabs, who met in 2022, have been on a long-term mission to break down vendor barriers, reduce costs, and create a scalable infrastructure for AI-driven laboratory automation, not only in Germany but also internationally.
- In Munich's thriving life sciences community, UniteLabs, a startup specializing in biotechnology, is working to set the global standard for lab automation, leveraging science, technology, business, finance, and the local community to make cutting-edge biotech research faster, smarter, and more connected than ever before.
